COMMUNIQUÉS West-GlobeNewswire

-
Novartis drug Promacta® receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
04/01/2018 -
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS AT JANUARY 1, 2018
04/01/2018 -
NOUVEAU NOMBRE D'ACTIONS ET DE DROITS DE VOTE D'INNATE PHARMA AU 1ER JANVIER 2018
04/01/2018 -
ABLYNX TO PRESENT AT THE 36th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
04/01/2018 -
Targovax announces that ONCOS-102 generates immune activation in checkpoint inhibitor refractory melanoma patients
04/01/2018 -
AVACOPAN CONDITIONAL MARKETING AUTHORIZATION APPLICATION ACCEPTED FOR REGULATORY REVIEW BY EUROPEAN MEDICINES AGENCY
04/01/2018 -
VELTASSA® APPROVED FOR MARKETING IN SWITZERLAND FOR THE TREATMENT OF HYPERKALAEMIA
04/01/2018 -
Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
04/01/2018 -
Helius Medical Technologies Announces Planned Five-for-One Reverse Stock Split
04/01/2018 -
INC Research/inVentiv Health Announces CFO Transition
03/01/2018 -
Skyline Medical Provides Sales Update on the STREAMWAY System
03/01/2018 -
Tabula Rasa HealthCare Engaged to Provide Opioid Education and Interventions to Physicians with Patients at High-Risk for Unintentional Misuse
03/01/2018 -
MPX Bioceutical Announces Beth Stavola Appointed to New Jersey Cannabis Industry Association Board of Trustees
03/01/2018 -
Dova Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
03/01/2018 -
Zynerba Pharmaceuticals Provides 2018 Clinical and Corporate Update
03/01/2018 -
MyoKardia to Present at 36th Annual J.P. Morgan Healthcare Conference
03/01/2018 -
Ascendis Pharma Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone for Pediatric Growth Hormone Deficiency
03/01/2018 -
Insmed Announces Additional Data from ALIS (Amikacin Liposome Inhalation Suspension) Phase 3 Clinical Program for Adult Patients with Treatment Refractory NTM Lung Disease Caused by MAC and Reports Progress with Commercial Preparations
03/01/2018 -
Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
Pages